Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry
Titel:
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry
Auteur:
Bjartell, Anders Lumen, Nicolaas Maroto, Pablo Paiss, Thomas Gomez-Veiga, Francisco Birtle, Alison Kramer, Gero Kalinka, Ewa Spaƫth, Dominique Feyerabend, Susan Matveev, Vsevolod Lefresne, Florence Lukac, Martin Wapenaar, Robert Costa, Luis Chowdhury, Simon